Clinton Group Holds Position in Enterprise Prods Partners L (EPD); Abbvie (ABBV) Shareholder Wall Street Access Asset Management Cut Its Holding as Stock Value Declined

Enterprise Products Partners L.P. (NYSE:EPD) Logo

Wall Street Access Asset Management Llc decreased its stake in Abbvie Inc (ABBV) by 45.68% based on its latest 2018Q3 regulatory filing with the SEC. Wall Street Access Asset Management Llc sold 4,468 shares as the company’s stock declined 6.62% with the market. The hedge fund held 5,314 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $502,000, down from 9,782 at the end of the previous reported quarter. Wall Street Access Asset Management Llc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $132.67B market cap company. The stock increased 0.44% or $0.39 during the last trading session, reaching $88.2. About 6.53M shares traded. AbbVie Inc. (NYSE:ABBV) has declined 7.04% since January 11, 2018 and is downtrending. It has underperformed by 7.04% the S&P500. Some Historical ABBV News: 09/04/2018 – AbbVie: Upadacitinib Meets All Primary and Ranked Secondary Endpoints; 25/05/2018 – AstraZeneca: Imfinzi Met Second Primary Endpoint of Overall Survival; 30/05/2018 – GILEAD SCIENCES INC – EPCLUSA IS FIRST PAN-GENOTYPIC HCV SINGLE TABLET REGIMEN (STR) APPROVED IN CHINA; 05/04/2018 – ABBVIE REPORTS GLOBAL RESOLUTION OF HUMIRA┬« (ADALIMUMAB) PATENT; 17/04/2018 – Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA┬« (pembrolizumab) in Melanoma at the 2018 American Association for Cancer Research Annual Meeting; 24/04/2018 – AstraZeneca: Imfinzi Monotherapy Wasn’t Powered for Statistical Significance; 25/05/2018 – Oncolytics Biotech Collaborates With USC Using Pelareorep in Combination With Keytruda, Velcade and Dexamethasone to Treat Multiple Myeloma; 22/03/2018 – BerGenBio to Present Overview of Phase Il Clinical Trial Portfolio Combining Bemcentinib With KEYTRUDA at 3rd Annual Immuno-Oncology Summit Europe; 09/04/2018 – ABBVIE: UPADACITINIB MEETS ALL PRIMARY, SECONDARY ENDPOINTS; 17/04/2018 – Blood-cancer treatments Imbruvica and Darzalex have boosted J&J’s pharmaceutical sales, while rheumatoid arthritis drug Remicade has been under pressure

Clinton Group Inc increased its stake in Enterprise Prods Partners L (EPD) by 107.68% based on its latest 2018Q3 regulatory filing with the SEC. Clinton Group Inc bought 11,924 shares as the company’s stock declined 10.65% with the market. The hedge fund held 22,998 shares of the natural gas distribution company at the end of 2018Q3, valued at $661,000, up from 11,074 at the end of the previous reported quarter. Clinton Group Inc who had been investing in Enterprise Prods Partners L for a number of months, seems to be bullish on the $59.10B market cap company. The stock decreased 0.33% or $0.09 during the last trading session, reaching $27.09. About 5.79 million shares traded. Enterprise Products Partners L.P. (NYSE:EPD) has risen 5.97% since January 11, 2018 and is uptrending. It has outperformed by 5.97% the S&P500. Some Historical EPD News: 30/04/2018 – ENTERPRISE PRODUCTS 1Q DISTRIBUTABLE CASH FLOW $1.39B; 04/04/2018 – China importers hope to sell U.S. cargoes to north Asia after tariff move; 24/05/2018 – Apache Dedicates Alpine High NGLs to Enterprise; 07/03/2018 – ENTERPRISE PRODUCTS PARTNERS HOLDS ANALYST DAY IN HOUSTON; 06/04/2018 – Enterprise Products Partners to Participate in Mizuho Energy Summit Conference; 10/04/2018 – Enterprise Pdts Partners Raises Distribution to 42.75c Vs. 42.25c; 21/04/2018 – DJ Enterprise Products Partners LP, Inst Holders, 1Q 2018 (EPD); 11/04/2018 – ENTERPRISE PRODUCTS PARTNERS – PURCHASED 65-ACRE WATERFRONT SITE ON HOUSTON SHIP CHANNEL FOR NEXT PHASE OF EXPANSION AT ENTERPRISE HYDROCARBON TERMINAL; 08/05/2018 – East Daley: Enterprise Products Partners Crushes Expectations, Exemplifies Health of the U.S. Oil and Gas Midstream Sector; 25/04/2018 – Enterprise Products Bond Trading 2x Average; Clients Net Buyers

More notable recent Enterprise Products Partners L.P. (NYSE:EPD) news were published by: Fool.com which released: “3 Top Energy Stocks to Buy Right Now – The Motley Fool” on January 02, 2019, also Seekingalpha.com with their article: “Enterprise Product Partners Is Poised For Massive Growth As NGL Production Soars – Seeking Alpha” published on November 21, 2018, Seekingalpha.com published: “Enterprises Products Partners +1.5% on strong Q3 results – Seeking Alpha” on October 31, 2018. More interesting news about Enterprise Products Partners L.P. (NYSE:EPD) were released by: Seekingalpha.com and their article: “Enterprise Products Partners declares $0.4325 dividend – Seeking Alpha” published on October 04, 2018 as well as Seekingalpha.com‘s news article titled: “Enterprise Products Partners Has Risen From The Oil Crash With Best-Of-Breed Assets And Best In Class Management – Seeking Alpha” with publication date: October 17, 2018.

Among 29 analysts covering Enterprise Products Partners LP (NYSE:EPD), 28 have Buy rating, 0 Sell and 1 Hold. Therefore 97% are positive. Enterprise Products Partners LP had 74 analyst reports since July 23, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Thursday, June 15 by Morgan Stanley. The stock has “Neutral” rating by Seaport Global on Friday, April 29. The stock of Enterprise Products Partners L.P. (NYSE:EPD) has “Strong-Buy” rating given on Tuesday, August 18 by Vetr. The stock has “Outperform” rating by Macquarie Research on Monday, April 24. Raymond James maintained the shares of EPD in report on Thursday, October 4 with “Strong Buy” rating. The stock has “Outperform” rating by Bernstein on Wednesday, May 11. The rating was maintained by Barclays Capital on Tuesday, January 31 with “Overweight”. The firm has “Buy” rating by BMO Capital Markets given on Thursday, October 12. The stock of Enterprise Products Partners L.P. (NYSE:EPD) earned “Buy” rating by Jefferies on Friday, January 12. On Wednesday, July 11 the stock rating was maintained by Barclays Capital with “Overweight”.

Since August 2, 2018, it had 5 insider buys, and 1 insider sale for $428,154 activity. Another trade for 10,000 shares valued at $261,900 was made by FOWLER W RANDALL on Tuesday, November 13. $250,000 worth of stock was bought by BARTH CARIN MARCY on Wednesday, December 19. $673,375 worth of Enterprise Products Partners L.P. (NYSE:EPD) was sold by HACKETT JAMES T on Monday, November 5.

Clinton Group Inc, which manages about $2.04 billion and $279.29 million US Long portfolio, decreased its stake in Archer Daniels Midland Co (NYSE:ADM) by 38,469 shares to 4,383 shares, valued at $220,000 in 2018Q3, according to the filing. It also reduced its holding in Avery Dennison Corp (NYSE:AVY) by 65,405 shares in the quarter, leaving it with 8,609 shares, and cut its stake in Adobe Sys Inc (NASDAQ:ADBE).

Investors sentiment decreased to 0.89 in 2018 Q3. Its down 0.12, from 1.01 in 2018Q2. It dived, as 40 investors sold EPD shares while 264 reduced holdings. 66 funds opened positions while 206 raised stakes. 754.87 million shares or 0.52% more from 750.99 million shares in 2018Q2 were reported. First Mercantile Trust Comm holds 0.24% of its portfolio in Enterprise Products Partners L.P. (NYSE:EPD) for 43,343 shares. Princeton Portfolio Strategies Gp Limited accumulated 75,706 shares or 0.57% of the stock. Moreover, Parallax Volatility Advisers Lp has 0% invested in Enterprise Products Partners L.P. (NYSE:EPD) for 14,072 shares. California Pub Employees Retirement Systems reported 3.02 million shares. Geode Ltd Liability has invested 0% in Enterprise Products Partners L.P. (NYSE:EPD). 3.20M are held by Citigroup. Beacon Fincl Group holds 0.11% or 22,849 shares in its portfolio. Ameriprise Fin has invested 0.04% in Enterprise Products Partners L.P. (NYSE:EPD). Homrich & Berg holds 107,907 shares. State Of New Jersey Common Pension Fund D reported 0.14% stake. Moreover, Sentinel Communications Lba has 13.44% invested in Enterprise Products Partners L.P. (NYSE:EPD). Hamlin Cap Limited Liability reported 3.53 million shares. Aull & Monroe Inv Management owns 0.59% invested in Enterprise Products Partners L.P. (NYSE:EPD) for 42,856 shares. The Missouri-based Atwood & Palmer has invested 0.03% in Enterprise Products Partners L.P. (NYSE:EPD). First Manhattan accumulated 140,056 shares or 0.02% of the stock.

Wall Street Access Asset Management Llc, which manages about $292.09M and $76.99 million US Long portfolio, upped its stake in Facebook Inc Cl A (NASDAQ:FB) by 2,910 shares to 7,444 shares, valued at $1.22 million in 2018Q3, according to the filing.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “Pfizer withdraws European marketing application for Humira biosimilar – Seeking Alpha” on December 14, 2018, also Seekingalpha.com with their article: “FDA to “take action” against branded drug makers using scare tactics to thwart biosimilar competition – Seeking Alpha” published on January 10, 2019, Streetinsider.com published: “AbbVie (ABBV), Tizona Therapeutics Report Strategic Collaboration to Develop First-in-Class Immunotherapy for Cancer Targeting CD39 – StreetInsider.com” on January 03, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Investorplace.com and their article: “5 Pharma Stocks That Could Cure Ailing Portfolios in 2019 – Investorplace.com” published on December 12, 2018 as well as Seekingalpha.com‘s news article titled: “60 Minutes to air piece on opioid drugmakers and distributors Sunday – Seeking Alpha” with publication date: December 14, 2018.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 25 before the open. They expect $1.92 earnings per share, up 29.73% or $0.44 from last year’s $1.48 per share. ABBV’s profit will be $2.89 billion for 11.48 P/E if the $1.92 EPS becomes a reality. After $2.14 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts -10.28% negative EPS growth.

Investors sentiment decreased to 0.82 in Q3 2018. Its down 0.12, from 0.94 in 2018Q2. It is negative, as 60 investors sold ABBV shares while 637 reduced holdings. 107 funds opened positions while 466 raised stakes. 994.12 million shares or 0.91% less from 1.00 billion shares in 2018Q2 were reported. Renaissance Lc has invested 0.93% in AbbVie Inc. (NYSE:ABBV). Moneta Group Inc Inv Advsrs Limited Liability Company owns 0.04% invested in AbbVie Inc. (NYSE:ABBV) for 3,875 shares. 9,755 were accumulated by Montrusco Bolton Investments Inc. Dnb Asset Management As reported 0% of its portfolio in AbbVie Inc. (NYSE:ABBV). Moreover, Raab & Moskowitz Asset Limited Liability Com has 0.49% invested in AbbVie Inc. (NYSE:ABBV) for 12,563 shares. Hillsdale Invest Mgmt stated it has 0.06% of its portfolio in AbbVie Inc. (NYSE:ABBV). Mcrae Mgmt invested 0.21% in AbbVie Inc. (NYSE:ABBV). Dynamic Advisor Solutions Lc reported 37,176 shares. Bnp Paribas Asset Mngmt Holdg Sa owns 275,197 shares. Sadoff Invest Limited Liability Company holds 2,723 shares. Monarch Capital Mgmt reported 55,544 shares or 1.9% of all its holdings. Sterling Capital Management Ltd Liability Corp reported 0.97% stake. Canada Pension Plan Investment Board invested in 0.45% or 2.56 million shares. Smithfield Trust has 0.29% invested in AbbVie Inc. (NYSE:ABBV) for 28,332 shares. Greatmark Investment Ptnrs invested in 0.96% or 32,153 shares.

Since August 17, 2018, it had 0 insider purchases, and 6 selling transactions for $26.66 million activity. SEVERINO MICHAEL had sold 50,000 shares worth $4.88 million on Friday, August 17. $2.25 million worth of AbbVie Inc. (NYSE:ABBV) shares were sold by Schumacher Laura J. Gosebruch Henry O sold $3.82 million worth of AbbVie Inc. (NYSE:ABBV) on Thursday, November 29. $1.50M worth of AbbVie Inc. (NYSE:ABBV) shares were sold by GONZALEZ RICHARD A.

Among 26 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 3 Sell and 13 Hold. Therefore 38% are positive. Abbvie Inc had 105 analyst reports since July 21, 2015 according to SRatingsIntel. Leerink Swann upgraded the stock to “Outperform” rating in Monday, October 2 report. As per Tuesday, April 10, the company rating was maintained by Piper Jaffray. The rating was maintained by Credit Suisse with “Hold” on Thursday, July 20. As per Friday, February 2, the company rating was maintained by Argus Research. The firm has “Buy” rating given on Wednesday, August 22 by Bank of America. William Blair initiated the stock with “Outperform” rating in Friday, February 5 report. The rating was maintained by BMO Capital Markets on Wednesday, October 11 with “Hold”. The firm has “Buy” rating by SunTrust given on Sunday, October 29. The stock has “Buy” rating by Jefferies on Monday, May 29. The company was downgraded on Monday, September 25 by UBS.

Enterprise Products Partners L.P. (NYSE:EPD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.